Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

To main content To sitemap To news Check availability details

A sustained release formulation of latanoprost for the treatment of Menière´s disease

Reference number
Coordinator SYNPHORA AKTIEBOLAG - SYNPHORA AB
Funding from Vinnova SEK 0
Project duration March 2014 - March 2015
Status Completed

Last updated 25 November 2019

Reference number 2014-00297